Related Experiment Video

Updated: Jul 29, 2025

Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway
07:15

Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway

Published on: August 23, 2024

489

Membranous nephropathy: Mechanistic insights and therapeutic perspectives

Meng-Ru Hua1, Yan-Long Zhao1, Jun-Zheng Yang2

  • 1Xi'an International Medical Center Hospital, Northwest University, No. 777 Xitai Road, Xi'an, Shaanxi 710000, China.

International Immunopharmacology
|May 19, 2023
PubMed

Insights

Membranous nephropathy (MN) involves autoimmune responses targeting kidney structures. Understanding autoantigens and immune pathways offers new diagnostic and therapeutic strategies for this common cause of nephrotic syndrome.

Area of Science:

  • Nephrology
  • Immunology
  • Pathogenesis of Kidney Diseases

Background:

  • Membranous nephropathy (MN) is a leading cause of adult nephrotic syndrome, distinct from diabetic causes.
  • Primary MN accounts for 80% of cases, while secondary MN is linked to systemic diseases or exposures.
  • Autoimmune reactions are central to MN pathogenesis.

Purpose of the Study:

  • To comprehensively review the immune pathogenesis of membranous nephropathy.
  • To discuss current and emerging interventions for MN.
  • To highlight unresolved issues and future research directions in MN.

Main Methods:

  • Review of scientific literature on MN pathogenesis, diagnosis, and treatment.
  • Analysis of the role of autoantigens (e.g., phospholipase A2 receptor, THSD7A) in immune responses.
  • Evaluation of complement activation, genetic factors, and environmental influences.

Main Results:

  • Identification of key autoantigens inducing IgG4-mediated humoral immune responses, crucial for MN diagnosis and monitoring.
  • Recognition of complement activation, genetic susceptibility, and environmental factors contributing to MN.
  • Current treatment combines supportive care with immunosuppressive drugs, balancing risks and benefits.

Conclusions:

  • Advances in understanding autoantigens provide new diagnostic and monitoring tools for MN.
  • Further research is needed to refine immunosuppressive therapies and address unresolved aspects of MN.
  • This review offers insights for clinicians and researchers in managing membranous nephropathy.
Keywords:
Anti-PLA(2)R antibodyAnti-THSD7A antibodyImmune pathogenesisImmunosuppressive therapyPrimary membranous nephropathy

More Related Videos

Using 2-Photon Microscopy to Quantify the Effects of Chronic Unilateral Ureteral Obstruction on Glomerular Processes11:47

Using 2-Photon Microscopy to Quantify the Effects of Chronic Unilateral Ureteral Obstruction on Glomerular Processes

Published on: March 4, 2022

2.3K
Induction of Nephrotic Syndrome in Mice by Retrobulbar Injection of Doxorubicin and Prevention of Volume Retention by Sustained Release Aprotinin07:38

Induction of Nephrotic Syndrome in Mice by Retrobulbar Injection of Doxorubicin and Prevention of Volume Retention by Sustained Release Aprotinin

Published on: May 6, 2018

8.5K

Related Concept Videos

Nephrotic Syndrome I : Introduction01:24

Nephrotic Syndrome I : Introduction

Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of...
11
Nephrotic Syndrome II : Assessment and Medical Management01:26

Nephrotic Syndrome II : Assessment and Medical Management

IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...
11
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
48
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
54
Mechanistic Models: Overview of Compartment Models01:21

Mechanistic Models: Overview of Compartment Models

Mechanistic models, a category encompassing both physiological and compartmental modeling, differ from empirical models' approaches to incorporating known factors about the systems being modeled. Empirical models describe data with minimal assumptions, while mechanistic models aim to provide a robust description of available data by specifying assumptions and integrating known factors about the system. Compartmental analysis is a key example of a mechanistic model in pharmacokinetics and...
124
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
472